Anuh Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

As of 27 Aug 2026, Anuh Pharma Ltd’s share price closed at ₹78.90, marking a 1.28% increase from the previous close of ₹77.90. The stock traded within a range of ₹77.01 to ₹79.49 during the day, remaining comfortably above its 52-week low of ₹66.72 but still below the 52-week high of ₹93.00. This price action reflects a cautious but positive sentiment among traders.

The technical trend has shifted from mildly bearish to mildly bullish, signalling a tentative recovery in price momentum. This is particularly significant given the stock’s micro-cap status and the volatility often associated with smaller pharmaceutical companies.

Moving Averages Signal Bullish Momentum

Daily moving averages have turned bullish, indicating that short-term price momentum is gaining strength. The stock’s price currently trades above its key daily moving averages, suggesting that buyers are increasingly active. This bullish crossover in moving averages often precedes further upward price movement, providing a technical foundation for optimism.

However, it is important to note that weekly and monthly moving averages have not yet confirmed this trend, with some longer-term indicators remaining bearish or neutral. This divergence between short-term and longer-term signals suggests that while immediate momentum is improving, the stock may still face resistance before a sustained uptrend is established.

MACD and RSI: Mixed Signals from Momentum Oscillators

The Moving Average Convergence Divergence (MACD) indicator remains bearish on both weekly and monthly timeframes. This indicates that the underlying momentum has not fully shifted to the upside, and the stock may still be in a consolidation phase. The MACD’s bearish stance suggests caution, as the momentum has yet to decisively confirm a bullish reversal.

Relative Strength Index (RSI) readings on weekly and monthly charts show no clear signal, hovering in neutral territory. This lack of extreme overbought or oversold conditions implies that the stock is not currently experiencing strong directional pressure, which aligns with the sideways movement observed in Bollinger Bands on the weekly timeframe.

Volume and Trend Confirmation: OBV and KST Indicators

On the volume front, the On-Balance Volume (OBV) indicator is mildly bullish on both weekly and monthly charts. This suggests that buying volume is gradually increasing, supporting the recent price gains. A rising OBV often precedes price appreciation, as it reflects accumulation by investors.

Conversely, the Know Sure Thing (KST) indicator remains mildly bearish on weekly and monthly timeframes, signalling that momentum may still be lagging behind price action. This mixed reading highlights the complexity of the current technical landscape, where volume and price trends are not fully aligned with momentum oscillators.

Dow Theory and Bollinger Bands: Contrasting Perspectives

According to Dow Theory, the weekly trend is mildly bearish, while the monthly trend has turned mildly bullish. This divergence indicates that while short-term price action may be under pressure, the longer-term outlook is beginning to improve. Investors should watch for confirmation of this monthly bullishness to validate a sustained uptrend.

Bollinger Bands on the weekly chart show sideways movement, reflecting a period of consolidation and low volatility. On the monthly chart, however, Bollinger Bands remain bearish, suggesting that the stock has yet to break out of its longer-term downtrend.

Comparative Returns and Market Context

When analysing Anuh Pharma’s returns relative to the broader market, the stock has outperformed the Sensex over shorter periods but lagged over longer horizons. For instance, over the past week, Anuh Pharma delivered a robust 3.83% return compared to the Sensex’s 0.73%. However, over the one-month period, the stock slightly declined by 0.29%, while the Sensex gained 1.86%.

Year-to-date, Anuh Pharma’s return stands at -1.96%, outperforming the Sensex’s steeper decline of -9.09%. Over one year, the stock has fallen 9.79%, underperforming the Sensex’s 4.10% loss. Longer-term returns over three, five, and ten years show the stock lagging the benchmark, with 17.67%, 33.73%, and 74.33% gains respectively, compared to Sensex returns of 19.40%, 38.47%, and 178.86%.

This performance profile suggests that while Anuh Pharma has demonstrated resilience in recent months, it remains a micro-cap stock with higher volatility and less consistent long-term growth compared to the broader market.

Mojo Score Upgrade and Analyst Ratings

MarketsMOJO has upgraded Anuh Pharma’s Mojo Grade from Sell to Hold as of 26 Aug 2026, reflecting the recent technical improvements and stabilising fundamentals. The current Mojo Score stands at 58.0, indicating a neutral stance with potential for upside if momentum continues to build.

This upgrade aligns with the mildly bullish technical trend and the improving daily moving averages, signalling that the stock may be entering a phase of consolidation before a possible breakout. Investors should monitor upcoming earnings and sector developments for confirmation.

Investor Takeaway and Outlook

In summary, Anuh Pharma Ltd is exhibiting early signs of technical recovery, with daily moving averages turning bullish and volume indicators supporting a mild uptrend. However, the persistence of bearish signals in MACD and KST on weekly and monthly charts suggests that the stock is still in a cautious phase, requiring confirmation before a sustained rally can be expected.

Investors should weigh the stock’s recent outperformance against the Sensex in the short term with its longer-term underperformance and micro-cap risks. The upgrade to a Hold rating by MarketsMOJO reflects this balanced view, recommending a watchful approach rather than aggressive accumulation at this stage.

Given the Pharmaceuticals & Biotechnology sector’s inherent volatility and regulatory sensitivities, monitoring technical indicators alongside fundamental developments will be crucial for making informed investment decisions in Anuh Pharma.

Key Technical Metrics Summary:

• Current Price: ₹78.90
• Daily Moving Averages: Bullish
• MACD (Weekly & Monthly): Bearish
• RSI (Weekly & Monthly): Neutral
• Bollinger Bands (Weekly): Sideways; (Monthly): Bearish
• KST (Weekly & Monthly): Mildly Bearish
• OBV (Weekly & Monthly): Mildly Bullish
• Dow Theory (Weekly): Mildly Bearish; (Monthly): Mildly Bullish
• Mojo Score: 58.0 (Hold)

As the stock navigates this technical transition, investors should remain vigilant for confirmation of bullish momentum, particularly through improvements in MACD and KST indicators and a breakout above recent resistance levels near ₹79.50.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →